# Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions

> **NCT03661801** · — · COMPLETED · sponsor: **University of Oxford** · enrollment: 313 (actual)

## Conditions studied

- Respiratory Disease
- Pleural Effusion
- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03661801
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-26
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 313 (ACTUAL)
- **Last updated:** 2020-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03661801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03661801, "Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03661801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*